Jiang S - Search Results

1

An amphiphilic conjugate approach toward the design and synthesis of betulinic acid-polyphenol conjugates as inhibitors of the HIV-1 gp41 fusion core formation.

Liu Y, Ke Z, Wu KY, Liu S, Chen WH, Jiang S, Jiang ZH. Liu Y, et al. Among authors: jiang s, jiang zh. ChemMedChem. 2011 Sep 5;6(9):1654-64. doi: 10.1002/cmdc.201100149. Epub 2011 Jun 17. ChemMedChem. 2011. PMID: 21688394

2

Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte.

Liu S, Jiang S, Wu Z, Lv L, Zhang J, Zhu Z, Wu S. Liu S, et al. Among authors: jiang s. Life Sci. 2002 Aug 30;71(15):1779-91. doi: 10.1016/s0024-3205(02)01939-2. Life Sci. 2002. PMID: 12151056

3

Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitors.

Liu S, Zhao Q, Jiang S. Liu S, et al. Among authors: jiang s. Peptides. 2003 Sep;24(9):1303-13. doi: 10.1016/j.peptides.2003.07.013. Peptides. 2003. PMID: 14706544

4

Rapid and automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41.

Liu S, Boyer-Chatenet L, Lu H, Jiang S. Liu S, et al. Among authors: jiang s. J Biomol Screen. 2003 Dec;8(6):685-93. doi: 10.1177/1087057103259155. J Biomol Screen. 2003. PMID: 14711394

5

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.

Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S. Liu S, et al. Among authors: jiang s. Lancet. 2004 Mar 20;363(9413):938-47. doi: 10.1016/S0140-6736(04)15788-7. Lancet. 2004. PMID: 15043961 Free PMC article.

6

High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniques.

Liu S, Jiang S. Liu S, et al. Among authors: jiang s. Curr Pharm Des. 2004;10(15):1827-43. doi: 10.2174/1381612043384466. Curr Pharm Des. 2004. PMID: 15180543 Review.

7

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine.

He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, Jiang S. He Y, et al. Among authors: jiang s. Biochem Biophys Res Commun. 2004 Nov 12;324(2):773-81. doi: 10.1016/j.bbrc.2004.09.106. Biochem Biophys Res Commun. 2004. PMID: 15474494 Free PMC article.

8

N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.

Jiang S, Lu H, Liu S, Zhao Q, He Y, Debnath AK. Jiang S, et al. Antimicrob Agents Chemother. 2004 Nov;48(11):4349-59. doi: 10.1128/AAC.48.11.4349-4359.2004. Antimicrob Agents Chemother. 2004. PMID: 15504864 Free PMC article.

9

Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120.

Liu S, Lu H, Niu J, Xu Y, Wu S, Jiang S. Liu S, et al. Among authors: jiang s. J Biol Chem. 2005 Mar 25;280(12):11259-73. doi: 10.1074/jbc.M411141200. Epub 2005 Jan 7. J Biol Chem. 2005. PMID: 15640162 Free article.

10

Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.

Liu S, Lu H, Zhao Q, He Y, Niu J, Debnath AK, Wu S, Jiang S. Liu S, et al. Among authors: jiang s. Biochim Biophys Acta. 2005 May 25;1723(1-3):270-81. doi: 10.1016/j.bbagen.2005.02.012. Epub 2005 Mar 24. Biochim Biophys Acta. 2005. PMID: 15823507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,905 results

Search Page

Filters